Literature DB >> 2045750

Disease concurrence in diabetes mellitus: a study of concurrent morbidity over 12 months using diabetes mellitus as an example.

D M Fleming1, D L Crombie, K W Cross.   

Abstract

STUDY
OBJECTIVE: The aim was to examine disease concurrence, using diabetes mellitus as an ullustrative example.
DESIGN: The study involved a general practice morbidity survey, conducted over 12 months in 1981-82. All patients who consulted their general practitioners with a diagnosis of diabetes mellitus (type 1 or type 2) were identified and the number of these who consulted with additional morbidities were counted for each rubric of the Royal College of General Practitioners' modification of the International Classification of Disease. These observed numbers were then compared with expected numbers calculated from the total non-diabetic population after standardisation by age. Standardised person consulting ratios (SPCR) were derived and the 99% confidence intervals (CI) surrounding these values calculated.
SETTING: This was a national survey involving the whole of England and Wales. PATIENTS: The study involved 280,000 patients from selected general practices, of whom 953 males and 1035 females consulted their general practitioners with diabetes.
MEASUREMENTS AND MAIN RESULTS: In an examination of 80 disease rubrics in the diabetic population in which there were at least 20 observed or expected cases, there were 34 among males and 28 among females in which there were increased values of the SPCR, and none in which the SPCR was decreased. SPCRs were high for infections generally (bacterial, fungal, and viral) and particularly so for cardiovascular disorders and for hypothyroidism in males. Though SPCRs for upper respiratory infections were increased, those for asthma and hay fever were not. SPCRs for neoplasms as a group were not raised.
CONCLUSION: By confirming other work and widely held clinical opinion, this study has shown the potential of this data base for the examination of disease concurrence.

Entities:  

Mesh:

Year:  1991        PMID: 2045750      PMCID: PMC1060706          DOI: 10.1136/jech.45.1.73

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  7 in total

Review 1.  Diabetes and the gut.

Authors:  J H Scarpello; G E Sladen
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

Review 2.  The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus.

Authors:  J E Craighead
Journal:  Prog Med Virol       Date:  1975

3.  Thyroid and gastric autoimmunity in patients with diabetes mellitus.

Authors:  W J Irvine; B F Clarke; L Scarth; D R Cullen; L J Duncan
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

4.  The association between carcinoma of the pancreas and diabetes mellitus.

Authors:  A J Karmody; J Kyle
Journal:  Br J Surg       Date:  1969-05       Impact factor: 6.939

5.  Studies of the epidemiology of staphylococcal infection. III. Clinical factors in susceptibility to staphylococcal disease.

Authors:  W R KEENE; B H MINCHEW; L E CLUFF
Journal:  N Engl J Med       Date:  1961-12-07       Impact factor: 91.245

6.  Studies on urinary infection in diabetics. I. Bacteriuria in patients with diabetes mellitus and in control subjects.

Authors:  R Vejlsgaard
Journal:  Acta Med Scand       Date:  1966-02

7.  Classification of idiopathic diabetes.

Authors:  W J Irvine
Journal:  Lancet       Date:  1977-03-19       Impact factor: 79.321

  7 in total
  4 in total

1.  Screening for diabetes.

Authors:  L A Pike; D L Crombie
Journal:  Br J Gen Pract       Date:  1997-11       Impact factor: 5.386

2.  Type 2 diabetes impairs pulmonary function in morbidly obese women: a case-control study.

Authors:  A Lecube; G Sampol; X Muñoz; C Hernández; J Mesa; R Simó
Journal:  Diabetologia       Date:  2010-03-09       Impact factor: 10.122

3.  Association between diabetes and increased prevalence of paranasal sinus disease: a cross-sectional study in Japanese adults.

Authors:  Yusuke Kabeya; Kiyoe Kato; Masuomi Tomita; Takeshi Katsuki; Yoichi Oikawa; Akira Shimada
Journal:  J Epidemiol       Date:  2015-02-28       Impact factor: 3.211

Review 4.  Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Fareeha Fiayyaz; Shakila Sabir; Mohsin Khurshid
Journal:  Arch Microbiol       Date:  2020-02-03       Impact factor: 2.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.